Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Wednesday, November 25, 2015 2:13:18 PM
bullish 4.42
## source: finance.yahoo.com
Tue, 17 Nov 2015 16:25:00 GMT ~ TTNP: Newly NASDAQ-listed Titan Moves Closer to Probuphine® Approval; Announces ProNeura-T3 for Hypothyroidism
read full: http://finance.yahoo.com/news/ttnp-newly-nasdaq-listed-titan-162500749.html
*********************************************************
Mon, 16 Nov 2015 21:34:07 GMT ~ Titan Pharmaceuticals Form 10-Q – For the Quarter Ended September 30, 2015 (November 16, 2015) (PDF document)
[at noodls] - 369c847a-d3a9-45aa-94a0-b3aff1752422.pdf UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q IR Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange ...
read full: http://www.noodls.com/view/2D0F4704753596887522132EAA0159AE66760BF4
*********************************************************
Mon, 16 Nov 2015 20:16:57 GMT ~ TITAN PHARMACEUTICALS INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
read full: http://biz.yahoo.com/e/151116/ttnp8-k.html
*********************************************************
Mon, 16 Nov 2015 19:07:18 GMT ~ TITAN PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
read full: http://biz.yahoo.com/e/151116/ttnp10-q.html
*********************************************************
Mon, 16 Nov 2015 13:35:05 GMT ~ November 16, 2015 - Titan Pharmaceuticals Adds Proneura Implant for Hypothyroidism to Product Development Pipeline
[at noodls] - TITAN PHARMACEUTICALS ADDS PRONEURA IMPLANT FOR HYPOTHYROIDISM TO PRODUCT DEVELOPMENT PIPELINE SOUTH SAN FRANCISCO, CA - Nov. 16, 2015 - Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a specialty pharmaceutical ...
read full: http://www.noodls.com/view/AA8943E6B046D83E1555C5E3C2819FF7ECD74EB4
*********************************************************
$TTNP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$TTNP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/TTNP/company-info
Ticker: $TTNP
OTC Market Place: Not Available
CIK code: 0000910267
Company name: Titan Pharmaceuticals, Inc.
Company website: http://www.titanpharm.com
Incorporated In: DE, USA
Business Description: Titan Pharmaceuticals Inc. (TTNP.OB), based in South San Francisco, CA, is a specialty pharmaceutical company developing proprietary therapeutics utilizing its ProNeura implant drug delivery technology. ProNeura provides non-fluctuating levels of medication continuously over periods of six months to a year and is ideal for use in the treatment of select chronic diseases for which subdermal delivery may offer advantages over oral administration.Titan's lead product candidate is Probuphine, a novel, subdermal implant formulation of buprenorphine designed to provide six months of medication for the maintenance treatment of opioid dependence following a single administration. A final Phase 3 trial of Probuphine is in progress, with results expected by mid-2015. Successful completion is expected to provide the clinical data requested by the FDA, and permit resubmission of the NDA later in 2015. Probuphine, which is licensed to Braeburn Pharmaceuticals for the U.S. and Canadian markets, has the potential to be approved in the U.S. in the first half of 2016. Titan is also in the early stages of developing a ProNeura-based product for the treatment of Parkinson's disease, and also investigating opportunities with other chronic treatments.Less >>
$TTNP share structure
## source: otcmarkets.com
Market Value: $85,054,400 a/o Nov 24, 2015
Shares Outstanding: 20,060,000 a/o Sep 29, 2015
Float: Not Available
Authorized Shares: Not Available
Par Value: 0.001
$TTNP extra dd links
Company name: Titan Pharmaceuticals, Inc.
Company website: http://www.titanpharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=TTNP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=TTNP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=TTNP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/TTNP/news - http://finance.yahoo.com/q/h?s=TTNP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/TTNP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/TTNP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=TTNP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/TTNP
DTCC (dtcc.com): http://search2.dtcc.com/?q=Titan+Pharmaceuticals%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Titan+Pharmaceuticals%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Titan+Pharmaceuticals%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.titanpharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.titanpharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.titanpharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/TTNP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000910267&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/TTNP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/TTNP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=TTNP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=TTNP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/TTNP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=TTNP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=TTNP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=TTNP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=TTNP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=TTNP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/TTNP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=TTNP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/TTNP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=TTNP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/TTNP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/TTNP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/TTNP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/TTNP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/TTNP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=TTNP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=TTNP
$TTNP DD Notes ~ http://www.ddnotesmaker.com/TTNP
Recent TTNP News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
- Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
- Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:33:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:31:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:29:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:25:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/26/2023 08:23:37 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 10/24/2023 09:26:34 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/23/2023 07:07:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:08:35 PM
- Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors • GlobeNewswire Inc. • 10/16/2023 08:37:23 PM
- Form SC 13D - General statement of acquisition of beneficial ownership • Edgar (US Regulatory) • 10/04/2023 09:30:18 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 09/19/2023 08:41:40 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 08:45:22 PM
- Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock • GlobeNewswire Inc. • 09/18/2023 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 09:30:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2023 08:28:25 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM